Acid blockers stop the absorption of all minerals, iron and vitamin B12, so nothing that is eaten benefits the body, the immune system stops working, and hair falls out.

Original statement

انا في ادويه منعتها قبل ما تقبلني اصلا قلتلك تمنعها نهائي من حياتك ادويه مثبطات الحموضه اللي انتوا كنتوا بتشوهات دي اللي هي بتاخدها الصبح قبل الفطار عشان بعد كده كل اللي يخش جسمك انت مش مستفاد بيه بعد كده اللي يخش جسمك كله مش هيلاقي جهاز مناعه شغال بعد كده كل الحديد اللي انت بتاخديه كل فيتامين بي 12 اللي بتاخديه مش هيمتس ما كنتش عارفين ليه ما كنتش عارفين شعركم بيقع عليه وانتم بتاخدوا الكنترلوك او النكس يا ما كنتش عارفين ان مثبطات الحموضه دي بتمنع امتصاص كل المعادن اصلا

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

Acid blockers stop the absorption of all minerals, iron and vitamin B12, so nothing that is eaten benefits the body, the immune system stops working, and hair falls out.

Origin

Source status

Video transcript (own words)

Attribution

Elawady (machine transcript)

Video

الادوية دورها انها تلحقك مش دورها انك تعيش عليها (Open source)

Published

2 April 2024

Timestamp

not available (transcript has no timings)

Attribution uncertainty

Machine-generated or CC transcript of a live stream; wording may contain transcription errors; context is conversational.

Claimed mechanism

Gastric acid is required for absorption of all nutrients.

Claimed health effect

Total malabsorption, immune failure, hair loss.

Population concerned

All PPI users.

Geographic restriction by Elawady

none found

Diverging source versions

Scientific assessment

Mostly false – Essential parts of the statement are not supported by the evidence or are strongly exaggerated.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

PPIs block absorption of all minerals and of everything eaten; immunity fails; hair falls out.

2. What is demonstrably correct?

Acid suppression can reduce absorption of vitamin B12 bound to food and has been associated with low magnesium (see C-PPI-03).

3. What is wrong or exaggerated?

'All minerals' and 'nothing you eat benefits you' are false: protein, fat and carbohydrate digestion and most micronutrient absorption continue, mainly in the small intestine with pancreatic enzymes. No evidence was found that PPIs make the immune system stop working or cause hair loss in general.

4. What remains unclear?

The size of effects on iron and calcium absorption in long-term users is less certain.

5. Which studies support it?

Partial support from A-PPI-09 and A-PPI-10 (B12, magnesium only).

6. Which studies contradict it?

COMPASS RCT (I-PPI-01): no excess of serious adverse events other than enteric infections over 3 years.

7. What applies to Germany and Europe?

PPIs are among the most widely prescribed drugs in Germany and Europe; several (e.g. pantoprazole, omeprazole) are sold over the counter in small packs for short-term use. European data (Stockholm, UK GPRD/CPRD, Rotterdam) are among the cited cohorts, so the observational findings apply to European users with the same confounding limits.

8. What is known about Egypt?

Elawady describes PPIs (Controloc, Nexium) as widely used and sold without prescription in Egypt. No Egypt-specific outcome data were reviewed. The biology and trial results are not expected to differ by country; H. pylori infection, which is common in many countries, is an additional reason why acid-suppression and eradication therapy are prescribed.

9. What practical conclusion is appropriate?

Nutrient-specific monitoring in long-term users is reasonable; the global statement is an exaggeration.

Assessment details

Rationale for certainty of evidence

Physiology and the observational data show partial, nutrient-specific effects (B12, magnesium, possibly iron and calcium) after long use, not global malabsorption. COMPASS (3 years, ~8,800 on pantoprazole) found no excess of major adverse outcomes except enteric infections.

Source quality

Video statement without evidence offered; machine transcript.

Regional transferability

Not region-specific.

Individual exceptions

Some individuals (e.g. atrophic gastritis, post-surgery, elderly) are more vulnerable to B12 or iron deficiency.

Regional scope of the claim

general (biological/medical)

Last reviewed

25 October 2026 provisional

In plain language

Acid blockers can lower the uptake of some nutrients, mainly vitamin B12 and magnesium, after long use. They do not stop the body from using food in general. Most digestion and absorption happens in the small intestine and continues normally. There is no good evidence that they switch off the immune system or make hair fall out.

Studies on this claim

Regional context

Germany / EU

PPIs are among the most widely prescribed drugs in Germany and Europe; several (e.g. pantoprazole, omeprazole) are sold over the counter in small packs for short-term use. European data (Stockholm, UK GPRD/CPRD, Rotterdam) are among the cited cohorts, so the observational findings apply to European users with the same confounding limits.

Egypt

Elawady describes PPIs (Controloc, Nexium) as widely used and sold without prescription in Egypt. No Egypt-specific outcome data were reviewed. The biology and trial results are not expected to differ by country; H. pylori infection, which is common in many countries, is an additional reason why acid-suppression and eradication therapy are prescribed.

What applies in my country?

General scientific assessment

Mostly false Exaggerated: PPIs affect a few nutrients, not the absorption of everything.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

1. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.. Lam JR et al.. JAMA 2013 · PMID 24327038 · DOI 10.1001/jama.2013.280490
2. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.. Kieboom BC et al.. Am J Kidney Dis 2015 · PMID 26123862 · DOI 10.1053/j.ajkd.2015.05.012
3. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.. Moayyedi P et al.. Gastroenterology 2019 · PMID 31152740 · DOI 10.1053/j.gastro.2019.05.056